Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats

Behavioural Brain Research

Volumn 267, Issue , 2014, Pages 1-5

  He, Zongsheng ^a   Chen, Yuan ^a   Dong, Huajin ^a   Su, Ruibin ^a   Gong, Zehui ^a   Yan, Lingdi ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Chicago sky blue 6B; Conditioned place preference; Methamphetamine; Vesicular glutamate transporters

Indexed keywords

CHICAGO SKY BLUE 6B; METHAMPHETAMINE; PROTEIN INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; PONTAMINE SKY BLUE; TRYPAN BLUE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL REWARD ADDICTION TEST; GLUTAMATERGIC TRANSMISSION; MALE; METHAMPHETAMINE DEPENDENCE; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; DEPTH PERCEPTION; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECTS; DRUG THERAPY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; TIME FACTORS; TRYPAN BLUE; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84897075395     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.02.047     Document Type: Article

References (35)

1. Aihara Y., Mashima H., Onda H., Hisano S., Kasuya H., Hori T., et al. Molecular cloning of a novel brain-type Na (+)-dependent inorganic phosphate cotransporter. J Neurochem 2000, 74:2622-2625.
2. Herzog E., Bellenchi G.C., Gras C., Bernard V., Ravassard P., Bedet C., et al. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 2001, 21:RC181.
3. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002, 22:5442-5451.
4. Kashani A., Lepicard E., Poirel O., Videau C., David J.P., Fallet-Bianco C., et al. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer's disease. Neurobiol Aging 2008, 29:1619-1630.
5. Oni-Orisan A., Kristiansen L.V., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 2008, 63:766-775.
6. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119-128.
7. Berke J., Hyman S. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000, 25:515-532.
8. Fujio M., Nakagawa T., Sekiya Y., Ozawa T., Suzuki Y., Minami M., et al. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine and morphine-induced conditioned place preference in rats. Eur J Neurosci 2005, 22:2744-2754.
9. Nakagawa T., Fujio M., Ozawa T., Minami M., Satoh M. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effect of morphine, methamphetamine and cocaine in mice. Behav Brain Res 2005, 156:233-239.
10. Fujio M., Nakagawa M., Suzuki Y., Satoh M., Kaneko S. Facilitative effect of a glutamate transporter inhibitor (2S,3S)-3-{3-[4-(trifluoromethyl) benzoylamino]benzyloxy}aspartate on the expression of methamphetamine-induced behavioral sensitization in rats. J Pharmacol Sci 2005, 99:415-418.
11. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glu-tamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 1992, 581:237-243.
12. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
13. Roseth S., Fykse E.M., Fonnum F. Uptake of l-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem 1995, 65:96-103.
14. Neale S.A., Copeland C.S., Salt T.E. Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex. Neurochem Int 2013, in press.
15. Baghbanzadeh A., Modirsaneie M., Emam G., Hajinezhad M. Microhandling of vesicular glutamate uptake modulate feeding in broilers. J Anim Physiol Anim Nutr (Berl) 2010, 94:74-77.
16. He Z., Yan L., Yong Z., Dong Z., Dong H., Gong Z. Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice. Behav Brain Res 2013, 239:172-176.
17. Paxinos G., Franklin K.B.J. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego, CA. 6th ed.
18. Baucum A.J., Rau K.S., Riddle E.L., Hanson G.R., Flekenstein A.E. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine and hyperthermia-associated mechanism. J Neurosci 2004, 24:3436-3443.
19. Knackstedt L.A., Melendez R.I., Kalivas P.W. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 2010, 67:81-84.
20. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009, 10:561-572.
21. Chesworth R., Brown R.M., Kim J.H., Lawrence A.J. The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice. PLoS One 2013, 8:e68371.
22. Cadet J.L., Jayanthi S. Epigenetics of methamphetamine-induced changes in glutamate function. Neuropsychopharmacology 2013, 38:248-249.
23. Baker D.A., Xi Z.X., Shen H., Swanson C.J., Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 2002, 22:9134-9141.
24. Reissner K.J., Kalivas P.W. Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol 2010, 21:514-522.
25. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 2003, 6:743-749.
26. Kau K.S., Madayag A., Mantsch J.R., Grier M.D., Abdulhameed O., Baker D.A. Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. Neuroscience 2008, 155:530-537.
27. Li S.M., Yin L.L., Shi J., Lin Z.B., Zheng J.W. The effect of 7-nitroindazole on the acquisition and expression of D-methamphetamine-induced place preference in rats. Eur J Pharmacol 2002, 435:217-223.
28. Shen F., Li Y.J., Shou X.J., Cui C.L. Role of the NO/sGC/PKG signaling pathway of hippocampal CA1 in morphine-induced reward memory. Neurobiol Learn Mem 2012, 98:130-138.
29. Katagiri H., Tanaka K., Manabe T. Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur J Neurosci 2001, 14:547-553.
30. Santos M.S., Li H., Voglmaier S.M. Synaptic vesicle protein trafficking at the glutamate synapse. Neuroscience 2009, 158:189-203.
31. King M.V., Kurian N., Qin S., Papadopoulou N., Westerink B.H., Cremers T.I., et al. Lentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognition. Neuropsychopharmacology 2014, 39(2):464-476.
32. El Mestikawy S., Wallén-Mackenzie A., Fortin G.M., Descarries L., Trudeau L.E. From glutamate co-release to vesicular synergy: vesicular glutamate, transporters. Nat Rev Neurosci 2011, 12:204-216.
33. Hnasko T.S., Chuhma N., Zhang H., Goh G.Y., Sulzer D., Palmiter R.D., et al. Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 2010, 65:643-656.
34. Amilhon B., Lepicard E., Renoir T., Mongeau R., Popa D., Poirel O., et al. VGLUT3 (Vesicular Glutamate Transporter Type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci 2010, 30:2198-2210.
35. Huston J.P., Silva M.A., Topic B., Müller C.P. What's conditioned in conditioned place preference?. Trends Pharmacol Sci 2013, 34:162-166.